Publication date
November 2000
DOI Publisher
Wiley ISSN
0277-0008 Journal
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyAbstract
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90037/1/phco.20.18.349S.34605.pd
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90037/1/phco.20.18.349S.34605.pd
At present, a constant progress in pathophysiology understanding and treatment of the chronic heart ...
Summary Myocardial ischemia results in myocardial dysfunction. Recovery may be delayed ('stunning'),...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
The progressive nature of heart failure (HF) is the predominant cause for the clinical course that t...
AbstractBecause physicians have traditionally considered heart failure to be a hemodynamic disorder,...
The central roles of neurohormonal abnormalities in the pathobiology of heart failure have been defi...
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers co...
Irrespective of the causes or the clinical manifestations of chronic heart failure (CHF), or even th...
Heart failure syndrome is defined as the inability of the heart to deliver adequate blood to the bod...
Therapy of heart failure. The incidence and prevalence of heart failure is on the rise. It has becom...
Disturbances in cardiovascular neural regulation, influencing both disease course and survival, prog...
Heart failure (HF), the leading cause of death in the western world, develops when a cardiac injury ...
The old heart failure (HF) treatments that increased contractility have generally increased also mo...
Cardiac dysfunction precipitates changes in vascular function, blood volume, and neurohormonal statu...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
At present, a constant progress in pathophysiology understanding and treatment of the chronic heart ...
Summary Myocardial ischemia results in myocardial dysfunction. Recovery may be delayed ('stunning'),...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
The progressive nature of heart failure (HF) is the predominant cause for the clinical course that t...
AbstractBecause physicians have traditionally considered heart failure to be a hemodynamic disorder,...
The central roles of neurohormonal abnormalities in the pathobiology of heart failure have been defi...
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers co...
Irrespective of the causes or the clinical manifestations of chronic heart failure (CHF), or even th...
Heart failure syndrome is defined as the inability of the heart to deliver adequate blood to the bod...
Therapy of heart failure. The incidence and prevalence of heart failure is on the rise. It has becom...
Disturbances in cardiovascular neural regulation, influencing both disease course and survival, prog...
Heart failure (HF), the leading cause of death in the western world, develops when a cardiac injury ...
The old heart failure (HF) treatments that increased contractility have generally increased also mo...
Cardiac dysfunction precipitates changes in vascular function, blood volume, and neurohormonal statu...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
At present, a constant progress in pathophysiology understanding and treatment of the chronic heart ...
Summary Myocardial ischemia results in myocardial dysfunction. Recovery may be delayed ('stunning'),...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
Add to ORKG